sdz 880-431 has been researched along with docetaxel anhydrous in 1 studies
Studies (sdz 880-431) | Trials (sdz 880-431) | Recent Studies (post-2010) (sdz 880-431) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
---|---|---|---|---|---|
5 | 0 | 0 | 12,110 | 3,216 | 6,920 |
Protein | Taxonomy | sdz 880-431 (IC50) | docetaxel anhydrous (IC50) |
---|---|---|---|
Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Manthey, CL; Qureshi, N; Stütz, PL; Vogel, SN | 1 |
1 other study(ies) available for sdz 880-431 and docetaxel anhydrous
Article | Year |
---|---|
Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; Docetaxel; Gene Expression; Lipid A; Macrophages; Mice; Mice, Inbred C3H; Microtubules; Paclitaxel; Phosphorylation; Signal Transduction; Taxoids; Tumor Necrosis Factor-alpha; Tyrosine | 1993 |